Neoadjuvant therapy using PD-1 inhibitor plus chemotherapy with different intervals between chemotherapy cycles for locally advanced gastric or gastroesophageal junction cancer: A randomized phase 2 study

被引：0
|
作者：
Gao, Quanli
Zhao, Lingdi
Zhao, Weijie
Wang, Zibing
Qin, Peng
Jiang, Zhiqiang
Huang, Jinxi
Zhang, Bin
Li, Zhimeng
Fu, Qiang
Zhao, Yuzhou
Ren, Yingkun
Shang, Chuang
Wan, Xiangbin
Gao, Yang
Xu, Yongchao
Yuan, Long
Lu, Chaomin
Li, Zhi
机构：
[1] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Immunol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[3] Henan Canc Hosp, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Surg Oncol, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[6] Zhengzhou Univ, Dept Surg Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4064
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer
    Xiong, Hui
    Li, Yun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3559 - 3570
  • [2] Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study
    Wang, Chunjing
    Wang, Zhen
    Zhao, Yue
    Wang, Fujing
    JOURNAL OF GASTRIC CANCER, 2023, 23 (02) : 328 - 339
  • [3] Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer
    Taherifard, Erfan
    Saeed, Anwaar
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [4] Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 study
    Shitara, K.
    Rha, S. Y.
    Wyrwicz, L. S.
    Oshima, T.
    Karaseva, N.
    Osipov, M.
    Yasui, H.
    Yabusaki, H.
    Afanasyev, S.
    Park, YK.
    Al-Batran, SE.
    Yoshikawa, T.
    Weber, P. E. Yanez
    Di Bartolomeo, M.
    Lonardi, S.
    Fang, X.
    Shih, CS.
    Bhagia, P.
    Bang, YJ.
    ANNALS OF ONCOLOGY, 2023, 34 : S1316 - S1316
  • [5] Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: A phase II study
    Newman, E
    Potmesil, M
    Ryan, T
    Marcus, S
    Hiotis, S
    Yee, H
    Norwood, B
    Wendell, M
    Muggia, F
    Hochster, H
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S97 - S100
  • [6] The safety and efficacy of neoadjuvant PD-1 inhibitor plus chemotherapy for patients with locally advanced gastric cancer: a systematic review and meta-analysis
    Yu, Zhiyuan
    Liang, Chen
    Xu, Qixuan
    Yuan, Zhen
    Chen, Miao
    Li, Rui
    Zhou, Sixin
    Li, Peiyu
    Wei, Bo
    Zhao, Xudong
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1415 - 1426
  • [7] Neoadjuvant cadonilimab (PD-1/CTLA-4 bispecific antibody) plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction cancer (GC/GEJC): A prospective, multi-center, phase II study
    Jiao, Zuoyi, Sr.
    Zhou, Huinian, Sr.
    Yu, Zyuaun, Sr.
    Long, Bo
    Huang, Zeping
    Zhao, Da
    Wei, Dengwen
    Zhao, Xiaonin
    Jiang, Zebin
    Yang, Xiaojun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Qian, Ting
    Liu, Delin
    Cao, Guochun
    Chen, Zhipeng
    Zhang, Qin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [9] Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trialA randomized clinical trial of neoadjuvant therapy for ESCC
    Yong Li
    Aiping Zhou
    Shuoyan Liu
    Ming He
    Keneng Chen
    Ziqiang Tian
    Yin Li
    Jianjun Qin
    Zhen Wang
    Haiquan Chen
    Hui Tian
    Yue Yu
    Wang Qu
    Liyan Xue
    Shun He
    Shuhang Wang
    Fenglong Bie
    Guangyu Bai
    Bolun Zhou
    Zhaoyang Yang
    Huiyao Huang
    Yan Fang
    Benjamin Li
    Xiangrong Dai
    Shugeng Gao
    Jie He
    BMC Medicine, 21
  • [10] Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial A randomized clinical trial of neoadjuvant therapy for ESCC
    Li, Yong
    Zhou, Aiping
    Liu, Shuoyan
    He, Ming
    Chen, Keneng
    Tian, Ziqiang
    Li, Yin
    Qin, Jianjun
    Wang, Zhen
    Chen, Haiquan
    Tian, Hui
    Yu, Yue
    Qu, Wang
    Xue, Liyan
    He, Shun
    Wang, Shuhang
    Bie, Fenglong
    Bai, Guangyu
    Zhou, Bolun
    Yang, Zhaoyang
    Huang, Huiyao
    Fang, Yan
    Li, Benjamin
    Dai, Xiangrong
    Gao, Shugeng
    He, Jie
    BMC MEDICINE, 2023, 21 (01)
12345